Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma

Blood

Volumn 105, Issue 5, 2005, Pages 1875-1880

  Vassilakopoulos, Theodoros P ^b   Angelopoulou, Maria K ^b   Constantinou, Nikos ^b   Karmiris, Themistoklis ^b   Repoussis, Panayiotis ^b   Roussou, Paraskevi ^b   Siakantaris, Marina P ^b   Korkolopoulou, Penelope ^b   Kyrtsonis, Marie Christine ^b   Kokoris, Styliani I ^b   Dimopoulou, Maria N ^b   Variamis, Eleni ^b   Viniou, Nora Athina ^b   Konstantopoulos, Konstantinos ^b   Dimitriadou, Evangelia M ^b   Androulaki, Athina ^b   Patsouris, Efstratios ^b   Doussis Anagnostopoulou, Ipatia A ^b   Panayiotidis, Panayiotis ^b   Boussiotis, Vassiliki A ^b   Kittas, Christos ^b   Pangalis, Gerassimos A ^a   more..

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANEMIA; BONE MARROW; BONE MARROW BIOPSY; CLINICAL FEATURE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; ILIAC ARTERY; INGUINAL REGION; LABORATORY TEST; LEUKOCYTE; LEUKOPENIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; ARTICLE; BONE MARROW CANCER; CANCER STAGING; HOSPITALIZATION; INCIDENCE; PATHOLOGY; PREDICTION AND FORECASTING; RISK; VALIDATION STUDY;

BONE MARROW NEOPLASMS; HODGKIN DISEASE; HUMANS; INCIDENCE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 20144362233     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-01-0379     Document Type: Review

References (17)

1. Munker R, Hasenclever D, Brosteanu O, Hiller E, Diehl V. Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. J Clin Oncol. 1995;13:403-409.
2. Bartl R. Frisch B. Burkhardt R, Huhn D, Pappen berger R. Assessment of bone marrow histology in Hodgkin's disease: correlation with clinical factors. Br J Haematol. 1982;51:345-360.
3. Doll DC, Ringenberg QS, Anderson SP, Hewett JE, Yarbro JW. Bone marrow biopsy in the initial staging of Hodgkin's disease. Med Pediatr Oncol. 1989;17:1-5.
4. Ellis ME, Diehl LF, Granger E, Elson E. Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: sensitivity and specificity of the Ann Arbor staging procedure criteria. Am J Hematol. 1989;30:115-120.
5. Spector N, Nucci M, Oliveira de Morais JC, et al. Clinical factors predictive of bone marrow involvement in Hodgkin's disease. Leuk Lymphoma. 1997;26:171-176.
6. O'Carroll DI, McKenna RW. Brunning RD. Bone marrow manifestations of Hodgkin's disease. Cancer. 1976;38:1717-1728.
7. Cimino G, Anselmo AP, de Luca AM, et al. Bone marrow involvement at onset of Hodgkin's disease. Tumori. 1983;69:47-51.
8. Howell SJ, Grey M, Chang J. et al. The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol. 2002; 119:408-411.
9. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. N Engl J Med. 1998;339:1506-1514.
10. Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, et al. Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites. Eur J Haematol. 2001;67:279-288.
11. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971;31:1860-1861.
12. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989;7:1630-1636.
13. Howard MR, Taylor PR, Lucrafl HH, Taylor MJ, Proc tor SJ. Bone marrow examination in newly diagnosed Hodgkin's disease: current practice in the United Kingdom. Br J Cancer. 1995;71:210-212.
14. Wang J. Weiss LM, Chang KL, et al. Diagnostic utility of bilateral bone marrow examination: significance of morphological and ancillary technique study in malignancy. Cancer. 2002;94:1522-1531.
15. Menon NC, Buchanan JG. Bilateral trephine bone marrow biopsies in Hodgkin's and non-Hodgkm's lymphoma. Pathology. 1979;11:53-57.
16. Vassilakopoulos TP, Pangalis GA. Application of a prediction rule to select which patients presenting with lymphadenopathy should undergo a lymph node biopsy. Medicine. 2000;79:338-347.
17. Mauch PM. Initial evaluation and diagnosis of Hodgkin's disease. UpToDate. version 11.3. http://www.uptodate.com.